Source: European Medicines Agency (EU) Revision Year: 2022 Publisher: Amryt Pharmaceuticals DAC, 45 Mespil Road, Dublin 4, Ireland
Mycapssa 20 mg gastro-resistant hard capsules.
Pharmaceutical Form |
---|
Gastro-resistant hard capsule (gastro-resistant capsule). White, size 0 enteric-coated hard gelatine capsules. |
Each gastro-resistant hard capsule contains octreotide acetate equivalent to 20 mg octreotide.
For the full list of excipients, see section 6.1.
Active Ingredient | Description | |
---|---|---|
Octreotide |
Octreotide is a synthetic octapeptide derivative of naturally occurring somatostatin with similar pharmacological effects, but with a considerably prolonged duration of action. It inhibits pathologically increased secretion of growth hormone (GH) and of peptides and serotonin produced within the GEP endocrine system. |
List of Excipients |
---|
Povidone |
Polychlorotrifluoroethylene [PCTFE]/polyethylene [PE]/polyvinylchloride [PVC]-aluminium blisters.
Pack size of 28 gastro-resistant hard capsules.
Amryt Pharmaceuticals DAC, 45 Mespil Road, Dublin 4, Ireland
EU/1/22/1690/001
Drug | Countries | |
---|---|---|
MYCAPSSA | Austria, Estonia, Croatia, Ireland, Italy, Lithuania, Poland, United States |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.